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1 |  INTRODUCTION
Gastric adenocarcinoma GA) is the fifth common ma-
lignancy in the world and is more common in men than 
in women. GA has been categorized based on the an-
atomical site of the tumor into two types; cardia gastric 
adenocarcinoma CGA) and non‐cardia gastric adenocarci-
noma NCGA).1 In 2012, approximately 951 000 new cases 
of GA were identified in the world. Of these, 27% and 73% 
were CGA and NCGA, respectively.2 Epidemiological 
studies have shown that NCGA is strongly associated with 
Helicobacter pylori infection2,3 such that 77% of the cases 
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Abstract
Iran is a high‐risk country for cardia gastric adenocarcinoma (CGA) in Central Asia, 
with an incidence rate five times the average global rate, and shows a high infection 
rate for Helicobacter pylori (69%). The aim was to examine the associations of mul-
tiple H. pylori cagPAI genotypes (ie cagH, cagL, cagG, and orf17) with the risk of 
CGA, non‐CGA, and different histological types of GA in Iran. A large number of H. 
pylori strains (N = 336) were successfully cultured and genotyped. Histopathological 
evaluations were performed. The analysis showed an inverse association between 
the cagH+ genotype and the risk of CGA and intestinal‐type gastric adenocarcinoma 
(IGA) (adjusted ORs; 0.312 and 0.283, respectively), where the controls were non-
tumors. The orf17+ genotype decreased the risk of non‐CGA and diffuse‐type gas-
tric adenocarcinoma (DGA)(adjusted ORs; 0.310 and 0.356, respectively). When the 
controls were those with nonatrophic gastritis, the cagG+ genotype was negatively 
associated with the risk of CGA, non‐CGA, IGA, and DGA (adjusted ORs; 0.324, 
0.366, 0.306, and 0.303, respectively). We did not find such a significant associa-
tion for the cagL+ genotype in multiple logistic regression analysis. Combination 
of the vacA c2 and cagPAI genotypes further decreased the risk estimates for GAs. 
This study showed the reverse association of H. pylori cagPAI genotypes—cagH+ 
and cagG+—with the risk of CGA in male patients aged ≥ 55 in Iran. Presence of 
the vacA c2 genotype in combination with cagPAI genotypes showed strong inverse 
associations with the risk of CGA and non‐CGA. These findings may reveal a coor-
dinated relationship between the vacA c2 and cagPAI genotypes.
K E Y W O R D S
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of NCGA are due to infection with this bacterium.4 In a 
meta‐analysis study, H. pylori has been suggested as a po-
tential risk factor for increasing the risk of CGA in high‐
risk areas. However, it shows a reverse link with the risk 
of CGA in low‐risk settings.5 Iran is a high‐risk country 
for CGA in Central Asia,2 with an incidence rate of five 
times the average global rate,2,6 and shows a high infection 
rate for H. pylori infection 69%).7 A considerable hetero-
geneity among H. pylori virulence genes may reflect the 
differences in the incidence of topographical subtypes and 
histological characteristics of the tumor.8,9
The cag pathogenicity island (cagPAI) is one of the 
most important virulence factors in H. pylori that encodes 
a type IV secretion system (T4SS) and has a clear correla-
tion with the progression of adenocarcinoma. The T4SS 
translocates the virulence factor cytotoxin‐associated gene 
A CagA) protein into gastric epithelial cells10 in which it 
plays an important role in the onset of GA. The T4SS bind-
ing to integrin receptors on gastric epithelial cells is a crit-
ical stage for translocation and delivery process of CagA 
protein. CagL is a pilus protein (26 kDa) and a specialized 
component for the T4SS that is able to bind to α5β1 inte-
grin receptor by the Arg‐ Gly‐Asp RGD) motif.11 CagH is 
another integrin‐binding protein of the T4SS with a mo-
lecular weight of 39 kDa and consists of 370 amino acids. 
It has a weak sequence similarity to CagL and is essential 
for the induction of IL‐8 secretion and CagA translocation 
into host gastric epithelial cells.12 Another gene of cagPAI, 
cagG, is located upstream of the cagA gene and encodes 
a protein with 142 amino acids. The cagG mutant strains 
are not capable of delivering CagA into the host cells.10,13 
The orf17 gene is another cagPAI gene (in cagPAI II) that 
has homology (36% identity) to one of the genes of the 
Dickeya zeae bacterium. Although the orf17 gene has no 
meaningful relationship with GC, it increases the risk of 
peptic ulceration in Iran.14
Some studies have shown that strains carrying the cagA 
gene are associated with a high risk of NCGA.15-19 and 
CGA.20 A significant association between vacA and NCGA, 
but not CGA, was also found.20,21 In another study, both 
CagA and VacA showed a relationship with an increased 
risk of intestinal‐type gastric adenocarcinoma IGA) and 
diffuse‐type gastric adenocarcinoma DGA).21 Furthermore, 
we identified the fifth polymorphic site at the vacA gene 
called c1/‐c2.22 The vacA c2 vs c1 genotype showed a very 
strong inverse association with the risk of CGA, non‐CGA, 
IGA, and DGA in male patients aged ≥ 55 in Iran.9 Taken 
altogether, the etiology of adenocarcinoma of the cardia is 
not known and still remains controversial. Therefore, the 
aim was to examine the associations of multiple H. pylori 
cagPAI genotypes (ie cagH, cagL, cagG, and orf17) with 
the risk of CGA and different histological types of GA in 
Iran.
2 |  MATERIALS AND METHODS
2.1 | Collection of biopsy specimens
Biopsy samples were collected from 744 patients with diges-
tive diseases referring to endoscopy units in different regions 
of Iran. Patients were classified into three groups including 
those with nonatrophic gastritis (NAG), gastric adenocarci-
noma (GA), and peptic ulcer (PU) disease. The study was 
approved by the research Ethics Committee of DDRC. All 
patients signed written informed consent.
2.2 | Endoscopy, histological 
examination, and cultivation
All the gastric biopsies were taken from the antrum and/or 
the corpus of patients—not from the tumor tissue itself—
one biopsy was used to test urease and another to cultivate. 
For tumor samples, histopathological examination was per-
formed based on the Sydney classification system and ac-
cording to our previous study.9 The anatomical region of 
the tumor was detected by the endoscopist. The tumors that 
originated from above the Z‐line—the lower one‐third of 
the esophagus—were considered as esophageal adenocar-
cinoma, but not CGA, and were thus excluded from all the 
analyses. The biopsies were cultured on selective culture 
medium of Brucella agar (Merck, Germany), enriched with 
7% defibrinated sheep blood, trimethoprim (5 mg/mL; MP 
Biomedicals, France), vancomycin (10  mg/mL; Zakaria, 
Iran), and amphotericin B (4  mg/ mL; Bristol‐Myers 
Squibb, USA). Plates were incubated under microaero-
bic conditions containing 5% CO2 and a moisture content 
above 98% for 4‐10 days at 37°C. The bacterial colonies 
were identified as H. pylori based on negative Gram's 
staining, showing typical spiral forms, urease, catalase, and 
oxidase positive tests, and detection of H. pylori ‐specific 
16S rDNA using PCR amplification.9
2.3 | DNA extraction and PCR amplification
DNA extraction from H. pylori strains was performed using 
SinaClon DNA extraction kit according to the manufactur-
er's instructions. Primers listed in Table S1 were used for 
PCR amplification and sequencing. PCR reaction and cycle 
parameters were performed as previously described.14 PCR 
products were loaded onto 1% Agarose gel containing safe 
stain and transferred to a gel Doc to view DNA bands under 
UV irradiation. For confirmatory purposes, an ABI3700XL 
DNA sequencer (Applied Biosystems) was used for se-
quencing the amplified fragments of each gene from 15 
strains. The nucleotide sequences were compared with 
those in GenBank by using the BLAST program (http://
www.ncbi.nlm.nih.gov).
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2.4 | Statistical analysis
Simple logistic regression analysis was used to investigate the 
effect of each factor on the risk of CGA, NCGA, and dif-
ferent histological types of GA. In this analysis, the Enter 
method was used as a model for the input of independent 
variables. Moreover, multiple logistic regression analysis 
was performed using the Forward Stepwise LR (Likelihood 
Ratio) method with adjustment for sex and a threshold age 
of ≥55 years. All the two‐sided P < 0.05 were considered 
as significant levels. Data were collected and analyzed using 
SPSS version 23. To estimate the Q‐value among the tested 
associations, we used the Q‐value package in R version 3.1.1.
3 |  RESULTS
3.1 | Patients' characteristics and 
relationship of age and sex with the risk of 
NCGA and CGA as well as IGA and DGA
A total of 336 H. pylori strains were successfully isolated 
from cultures of the biopsy specimens of Iranian patients 
(64.6% males and 36.4% females; 48.8% age ≥ 55 years and 
50.6% age < 55 years). Based on endoscopic findings, the 
patients included 127 cases (56 with CGA, 66 with NCGA, 
and five with both the types of CGA and NCGA) and 209 
controls (153 with NAG and 56 with PU) (Table 1). GA was 
more common in the group of males and the age group of 55 
and older. Simple logistic regression analysis showed a sig-
nificant association between male gender or age ≥ 55 years 
and the risk of NCGA and CGA as well as IGA and DGA, 
when the controls were nontumors or those with NAG. 
(P < 0.05; Table S2).
3.2 | Association between the cagPAI 
genotypes (cagH, cagL, cagG, and orf17) and 
NCGA and CGA as well as IGA and DGA
Among 336 strains, the total frequencies of cagH+, cagL+, 
cagG+, and orf17+ genotypes were 51.2% (172/336), 78.3% 
(263/336), 62.2% (209/336), and 53.0% (178/336), respec-
tively. In Table 2, the risk estimates for GA in relation to H. 
pylori cagPAI genotypes have been described using simple 
logistic regression analysis, where the controls were nontu-
mors (patients with either NAG or PU). The simple logis-
tic regression analysis demonstrated that the cagH+, cagL+, 
cagG+, and orf17+ genotypes had significant reverse as-
sociations with risk of both CGA and the NCGA; the OR 
(95% CI) for cagH+ was 0.260 (0.138‐0.490) and 0.318 
(0.179‐0.568), respectively, cagL+ 0.326 (0.166‐0.641) and 
0.335 (0.176‐0.637), respectively, cagG+ 0.375 (0.205‐0.367) 
and 0.294 (0.166‐0.552), respectively, and orf17+ 0.293 
(0.158‐0.546) and 0.327 (0.184‐0.580), respectively. Based 
on the results of the simple logistic regression analysis (Table 
3), when the controls were NAG, the cagH+, cagL+, cagG+, 
and orf17+ genotypes were inversely associated again with 
both CGA and the NCGA; the OR (95% CI) for cagH+ was 
0.313 (0.163‐0.603) and 0.385 (0.211‐0.701), respectively, 
cagL+ 0.455 (0.230‐0.904) and 0.468 (0.244‐0.898), respec-
tively, cagG+ 0.342 (0.181‐0.647) and 0.269 (0.150‐0.482), 
respectively, and orf17+ 0.369 (0.195‐0.700) and 0.411 
(0.227‐0.745), respectively.
When further analysis was performed based on the his-
tological characteristics of the tumor, the frequency of the 
cagH+, cagL+, cagG+, and orf17+ genotypes in patients 
with IGA (28.0%, 66.7%, 44.0%, and 34.7%, respectively) 
and DGA (38.5%, 69.2%, 43.6%, and 41.0%, respectively) 
was lower than in those with no tumors (62.7%, 85.6%, 
72.7%, and 63.6%, respectively) (Table 2). These gen-
otypes showed significant reverse associations with the 
risk of IGA (the OR (95% CI) was 0.232 (0.130‐0.412), 
0.335 (0.181‐0.621), 0.295 (0.170‐0.510), and 0.303 
(0.174‐0.527), respectively) and DGA (the OR (95% CI) 
was 0.372 (0.184‐0.752), 0.377 (0.172‐0.824), 0.290 
(0.144‐0.585), and 0.398 (0.198‐0.799), respectively) in 
simple logistic regression analysis (Table 3).
T A B L E  1  Characteristics of patients enrolled in this study
Characteristics
No. of patients 
(%)
Age groups
≥55 164/336 (48.8)
<55 170/336 (50.6)
No data 2/336 (0.6)
Sex groups
Males 217/336 (64.6)
Females 119/336 (36.4)
Types of gastroduodenal diseases
Control 209/336 (62.2)
Nonatrophic gastritis 153/209 (73.2)
Peptic ulcer 56/209 (26.8)
Case 127/336 (37.8)
Cardia gastric adenocarcinoma 56/127 (44.1)
Non‐cardia gastric adenocarcinoma 66/127 (52.0)
Unspecified 5/127 (3.9)
Intestinal‐type adenocarcinoma 75/127 (59.1)
Diffuse‐type adenocarcinoma 39/127 (30.7)
Mucin producing‐type adenocarcinoma 5/127 (3.9)
Signet ring‐type adenocarcinoma 4/127 (3.1)
Adenocarcinoma, poorly differentiated 3/127 (2.4)
Adenocarcinoma, moderate differentiation 1/127 (0.8)
Total 336/336 (100)
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Where the controls were those with NAG, the cagH+, 
cagL+, cagG+, and orf17+ genotypes were significantly 
associated with a decreased risk of IGA; the OR (95% 
CI) was 0.280 (0.154‐0.508), 0.468 (0.250‐0.876), 0.269 
(0.150‐0.482) and 0.382 (0.215‐0.677), respectively. The 
cagG+ genotype was inversely associated with the risk of 
DGA; the OR (95% CI) was 0.264 (0.127‐0.549) (Table 3).
Eventually, in a multiple logistic regression analysis, the 
cagH+ genotype was negatively correlated with the age‐ and 
sex‐adjusted risk for CGA and IGA, and the orf17+ geno-
type for NCGA and DGA, where the controls were nontu-
mors; the OR (95% CI) for cagH+ was 0.312 (0.150‐0.651) 
and 0.283 (0.148‐0.543), respectively and for orf17+ 0.310 
(0.158‐0.607) and 0.356 (0.154‐0.826), respectively. The 
multiple logistic regression analysis also showed an inverse 
association between the cagG+ genotype and the adjusted 
risk for CGA, NCGA, IGA, and DGA, where the con-
trols were those with NAG (the ORs [95% CI] were 0.324 
[0.139‐0.759], 0.366 [0.175‐0.762], 0.306 [0.150‐0.625], and 
0.303 [0.116‐0.790], respectively) (Table 4).
3.3 | Association 
between the presence of the vacA c2 genotype 
in combination with the cagPAI genotypes 
(cagH, cagL, cagG, and orf17) and NCGA and 
CGA as well as IGA and DGA
As illustrated in Table 5, when the controls were nontu-
mors, the presence of vacA c2 in combination with cagPAI 
genotypes further reduced the risk of both CGA and the 
NCGA. The OR for cagH/vacAc2 was 0.109 (0.037‐0.321) 
and 0.134 (0.054‐0.333), respectively, cagL/vacAc2 0.172 
(0.078‐0.384) and 0.112 (0.051‐0.250), respectively, cagG/
vacAc2 0.259 (0.115‐0.582) and 0.119 (0.048‐0.296), re-
spectively, and orf17/vacAc2 0.125 (0.046‐0.337) and 0.119 
(0.048‐0.296), respectively. Further analysis revealed that 
there was an inverse relationship between the four combina-
tions of cagPAI genotypes with vacA c2 genotype and the 
risk of both IGA and DGA (Table 5). The results of simple 
logistic regression analysis for the associations of combina-
tion genotypes (vacA c2 region genotype in combination with 
the cagPAI genotypes) with GA risk are shown in Table 6, 
where the controls are NAG.
4 |  DISCUSSION
For men in Iran, the incidence rate of CGA is twice the rate 
of NCGA, unlike what is observed worldwide.2 In the pre-
sent study, more than 80% of patients in CGA group and 
more than 70% of patients in NCGA group were males and 
had age  ≥  55  years. CGA was approximately seven times 
more common among men (87.5%) than women (12.5%). TA
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Furthermore, we found significant associations between 
male gender or age ≥ 55 and the risk of CGA and NCGA, 
where the controls were nontumors (ORs  =  5.83 vs 2.83 
and ORs = 15.51 vs 12.69, respectively) or those with NAG 
(ORs  =  8.75 vs 4.25 and ORs  =  17.38 vs 14.224, respec-
tively). Statistical analysis revealed a very strong correlation 
between age ≥ 55 and DGA compared to IGA. The OR was 
47.84 (vs 9.37) when the controls were nontumors. The OR 
estimate also was 53.603 (vs 10.50) when the controls were 
those with NAG.
The reason for a higher incidence of CGA in Iran is un-
known; however, a high infection rate for H. pylori 69%)7 
and a considerable heterogeneity among H. pylori viru-
lence genes may contribute to a high rate of CGA in the 
Iranian population. In a case‐control study in Northeastern 
Iran, CagA seropositivity was related to an increased risk 
of both CGA OR = 1.9) and NCGA OR = 3.4). A signif-
icant association was also found between seropositivity to 
VacA antigen and risk of NCGA OR = 2.8), but not CGA.20 
However, several studies from different parts of the world 
have shown that there was no association between CagA 
antibodies and CGA.21,23 There was no significant statis-
tical correlation between the cagA+ genotype and the risk 
of CGA.9,21 However, other studies revealed an inverse as-
sociation between cagA+ strains and the development of 
CGA.24,25
The cagH+ genotype showed significant reverse associa-
tions with the risk of both CGA and the NCGA. Also when 
the controls were NAG, the cagH + genotype was inversely 
associated again with both CGA.
It has been demonstrated that more than 85% of the H. py-
lori strains isolated from patients in India, Malaysia, Taiwan, 
Iran, and Singapore were cagL positive.14,26,27 No association 
was found between this genotype and clinical outcomes.27-31 
These results were consistent with the results of the Raei et 
al study for GC, but not for PU OR = 10.950).14 In the pres-
ent study, 78.3% of strains had the cagL+ genotype and the 
results of logistic regression analysis showed a significant re-
verse association between this genotype and the risk of CGA 
and NCGA, whether the controls were nontumors or those 
with NAG.
Various studies from Asian countries such as China, 
Korea, Japan, and Iran showed that although there was a high 
prevalence of cagG+ genotype in these populations (91.7%, 
86.7%, 97%, and 71.5%, respectively), no significant associ-
ation with gastrointestinal diseases was found.14,32,33 In the 
present study, the cagG+ genotype was the most frequent after 
the cagL+ genotype and showed a significant, but inverse as-
sociation with the risk of both CGA and NCGA, whether the 
controls were nontumors or those with NAG.
The orf17 genotype, like the cagH genotype, has not been 
well studied at the genomic level; only one study from Iran re-
vealed that the orf17 genotype had a remarkable relationship 
with an increased risk of PU (OR  =  2.504) but not GC.14 
However, in the present study, a remarkable but negative rela-
tionship was found between the orf17+ genotype and the risk 
of CGA and NCGA, whether the controls were nontumors or 
those with NAG.
The associations of some H. pylori genotypes and their 
role in the development of histological types of GC have been 
confirmed in previous studies.21,34 In a study from Sweden, 
CagA and VacA antibodies were linked to a heightened risk 
of both intestinal‐ (ORs = 6.0 and 3.7, respectively) and dif-
fuse‐ (ORs = 20.6 and 3.9, respectively) type GC.21 In the 
present study, significant reverse associations of the cagH+, 
cagL+, cagG+, and orf17+ genotypes with the risk of IGA 
and DGA were found, where the controls were nontumors. 
The results of simple logistic regression analysis, where the 
controls were those with NAG, demonstrated that the cagH+, 
cagL+, cagG+, and orf17+ genotypes were associated with a 
decreased risk of IGA, and only cagG+ genotype had a signif-
icant reverse relationship with the risk of DGA.
Eventually, in the multiple logistic regression analysis, 
after being adjusted for confounding factors, the cagG+ gen-
otype was associated with a reduced risk of CGA and NCGA 
as well as IGA and DGA (the adjusted ORs = 0.324, 0.366, 
0.306, and 0.303, respectively), where the controls were those 
with NAG. However, when the control groups were nontu-
mors, there were variations between the associations of cag-
PAI genotypes with the risk of CGA or non‐CGA and IGA or 
DGA, so that the the cagH+ genotype had a strong correla-
tion with a reduced risk of CGA and IGA (ORs = 0.312 and 
0.283, respectively), and the orf17+ genotype had a negative 
correlation with the risk of NCGA and DGA (ORs = 0.310 
and 0.356, respectively).
These findings are the first report on a reverse association 
of H. pylori cagPAI genotypes with the risk of CGA in male 
patients aged ≥ 55 in Iran. In the present study, the presence 
of the vacA c2 genotype in combination with cagPAI gen-
otypes showed strong inverse associations with the risk of 
CGA. These findings may reveal a coordinated relationship 
between the vacA c2 and cagPAI genotypes; however, it is 
still vague and requires more research.
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